A RAND study comparing hospital prices across states provided insights into the drivers of high healthcare spending in Michigan, explained Bret Jackson, president of the Economic Alliance for Michigan.
A RAND study comparing hospital prices across states provided insights into the drivers of high healthcare spending in Michigan, explained Bret Jackson, president of the Economic Alliance for Michigan.
Transcript
Michigan recently participated in a RAND study comparing hospital prices for privately insured patients to a Medicare benchmark. What were the results?
The results showed wide variation of hospital prices, especially outpatient prices, across the country. And it was really staggering what the differences were from state to state. Michigan actually fared pretty well in having some of the lowest prices in the country. However, we know that our premiums are above average for the states that are in the study and that total spending of healthcare is high in Michigan. And so, now that we know that prices are low, we know that the problem lies in utilization.
This was version 2.0 of the RAND study. What was the purpose of it and how did it differ from the 1.0 version? What is next?
They had done the study, they had just looked at Indiana, and then afterwards they were like, “Okay, well this seems like it’s high, but we have no idea how that compares to anybody else,” because they had no benchmark. So the 2.0 study was a 25-state study, looking at how Indiana compared to all the other states that participated. Now we’re trying to look at a 3.0 study, where we’re trying for a 50-state strategy so we can compare how everybody’s doing.
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Patient-Reported QOL Outcomes of Initial CLL Treatments: ASH 2024
January 8th 2025Quality-of-life (QOL) outcomes vary widely for patients receiving first-line treatment for chronic lymphocytic leukemia (CLL), according to research presented at the 2024 American Society of Hematology (ASH) meeting.
Read More